NCT05004025View on ClinicalTrials.gov

Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

November 18, 2024

Study Completion Date

July 23, 2025

Conditions
Uveal Melanoma
Interventions
DEVICE

Novocure Optune

Novacure Optune with Opdivo and Yervoy

DRUG

Opdivo

Novacure Optune with Opdivo and Yervoy

DRUG

Yervoy

Novacure Optune with Opdivo and Yervoy

Trial Locations (2)

85258

HonorHealth Research Institute, Scottsdale

90025

The Angeles Clinic and Research Insititute, Los Angeles

Sponsors
All Listed Sponsors
collaborator

NovoCure Ltd.

INDUSTRY

lead

HonorHealth Research Institute

OTHER